Ablation Safe, Effective for First-Line Atrial Fib Treatment
Author and Disclosure Information
FROM THE ANNUAL MEETING OF THE HEART RHYTHM SOCIETY
The trial was sponsored by the Population Health Research Institute and McMaster University and Hamilton Health Sciences. It was supported by grant-in-aid from Biosense Webster. Dr. Morillo disclosed receiving consulting fees/honoraria/research grants from and/or being on a speakers bureau for Boehringer Ingelheim, Sanofi, Medtronic, Merck, St. Jude Medical, Boston Scientific, and Biosense Webster. Dr. Fogel disclosed that he has received grants for clinical research and educational activities from St. Jude Medical, Medtronic, and Guidant, and owns stock in Medtronic and Guidant.